부산대학교 도서관

Background Secreted frizzled-related protein (Sfrp)5 improves insulin sensitivity, but impairs beta-cell function in rodents. However, the relationship between Sfrp5, insulin sensitivity and secretion in humans is currently unclear. Therefore, the aim of the study was to characterize the associations between serum Sfrp5 and indices of insulin sensitivity and beta-cell function from dynamic measurements using oral glucose tolerance tests ( OGTT) in humans. Material and methods This study enrolled 194 individuals with nonalcoholic fatty liver disease ( NAFLD), who were diagnosed based on ultrasound and liver transaminases and underwent a frequent sampling 75-g OGTT. Fasting serum Sfrp5 was measured by ELISA. Associations were assessed with several indices of insulin sensitivity and beta-cell function derived from glucose, insulin and C-peptide concentrations during the OGTT. Results Circulating Sfrp5 associated inversely with the insulinogenic index based on C-peptide ( rs = −0·244, P = 0·001), but not with the insulinogenic index based on insulin levels ( rs = −0·007, P = 0·926) after adjustment for age, sex and body mass index. Sfrp5 inversely correlated only with QUICKI as a marker of insulin sensitivity in the model adjusted for age and sex ( rs = −0·149, P = 0·039). These associations were not influenced by the additional adjustment for hepatic steatosis index. Conclusions The inverse association of serum Sfrp5 with beta-cell function suggests a detrimental role of Sfrp5 for insulin secretion also in humans. The severity of NAFLD does not appear to affect this relationship. The weak association between serum Sfrp5 and insulin sensitivity was partially explained by body mass. [ABSTRACT FROM AUTHOR]